Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial.
Serruys PW, Degertekin M, Tanabe K, Russell ME, Guagliumi G, Webb J, Hamburger J, Rutsch W, Kaiser C, Whitbourn R, Camenzind E, Meredith I, Reeves F, Nienaber C, Benit E, Disco C, Koglin J, Colombo A; TAXUS II Study Group. Serruys PW, et al. Among authors: benit e. Circulation. 2004 Feb 10;109(5):627-33. doi: 10.1161/01.CIR.0000112566.87022.32. Circulation. 2004. PMID: 14769685 Clinical Trial.
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents.
Pinxterhuis TH, Ploumen EH, Doggen CJM, Hartmann M, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Linssen GCM, von Birgelen C. Pinxterhuis TH, et al. Among authors: benit e. Eur Heart J Acute Cardiovasc Care. 2023 Nov 16;12(11):774-781. doi: 10.1093/ehjacc/zuad098. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 37619976 Free PMC article.
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
Pinxterhuis TH, Ploumen EH, Zocca P, Doggen CJM, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Stoel MG, Linssen GCM, Geelkerken RH, von Birgelen C. Pinxterhuis TH, et al. Among authors: benit e. Int J Cardiol. 2023 Mar 1;374:27-32. doi: 10.1016/j.ijcard.2022.12.009. Epub 2022 Dec 7. Int J Cardiol. 2023. PMID: 36496036 Free article.
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention.
Pinxterhuis TH, Ploumen EH, Zocca P, Doggen CJM, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Hartmann M, Linssen GCM, von Birgelen C. Pinxterhuis TH, et al. Among authors: benit e. Front Cardiovasc Med. 2023 Sep 7;10:1160201. doi: 10.3389/fcvm.2023.1160201. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745109 Free PMC article.
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, van den Bos A, Benit E, Anzuini A, Rutsch W, Legrand V, Dawkins K, Cobaugh M, Bressers M, Backx B, Wijns W, Colombo A. Serruys PW, et al. Among authors: benit e. J Am Coll Cardiol. 2002 Feb 6;39(3):393-9. doi: 10.1016/s0735-1097(01)01760-0. J Am Coll Cardiol. 2002. PMID: 11823075 Free article. Clinical Trial.
The NUGGET study: NIR ultra gold-gilded equivalency trial.
Reifart N, Morice MC, Silber S, Benit E, Hauptmann KE, de Sousa E, Webb J, Kaul U, Chan C, Thuesen L, Guagliumi G, Cobaugh M, Dawkins K; NUGGET Study. Reifart N, et al. Among authors: benit e. Catheter Cardiovasc Interv. 2004 May;62(1):18-25. doi: 10.1002/ccd.20026. Catheter Cardiovasc Interv. 2004. PMID: 15103594 Clinical Trial.
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent.
Duckers HJ, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys PW. Duckers HJ, et al. Among authors: benit e. EuroIntervention. 2007 May;3(1):67-75. EuroIntervention. 2007. PMID: 19737687
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent).
Duckers HJ, Soullié T, den Heijer P, Rensing B, de Winter RJ, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys PW. Duckers HJ, et al. Among authors: benit e. EuroIntervention. 2007 Nov;3(3):350-8. doi: 10.4244/eijv3i3a64. EuroIntervention. 2007. PMID: 19737717
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients.
den Dekker WK, Houtgraaf JH, Onuma Y, Benit E, de Winter RJ, Wijns W, Grisold M, Verheye S, Silber S, Teiger E, Rowland SM, Ligtenberg E, Hill J, Wiemer M, den Heijer P, Rensing BJ, Channon KM, Serruys PW, Duckers HJ. den Dekker WK, et al. Among authors: benit e. Atherosclerosis. 2011 Nov;219(1):245-52. doi: 10.1016/j.atherosclerosis.2011.06.032. Epub 2011 Jun 25. Atherosclerosis. 2011. PMID: 21763653 Free article. Clinical Trial.
102 results